Principal Investigator
Aman Chauhan
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20220847
Clinical Trial Summary
A Phase 1b Trial of M3814 (Peposertib) in Combination with Lutetium 177 Dotatate for Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Phase
Phase I
Funding Agency/Sponsor
National Cooperative Group
Disease
Stomach and Esophageal Cancer
Contact Information
Phone Number
305-243-2647